1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Peripheral Vascular Devices Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 12
3 Peripheral Vascular Devices Market, United States 16
3.1 Peripheral Vascular Devices Market, United States, Revenue ($m), 2015-2025 16
3.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2015-2025 19
3.1.2 Carotid and Renal Artery Stents Market, United States, Revenue ($m), by Segment, 2015-2025 21
3.1.3 Peripheral Embolic Protection Devices Market, United States, Revenue ($m), by Segment, 2015-2025 23
3.1.4 Peripheral Guidewires Market, United States, Revenue ($m), by Segment, 2015-2025 25
3.1.5 Peripheral Vascular Stents Market, United States, Revenue ($m), by Segment, 2015-2025 27
3.1.6 PTA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 29
3.1.7 PV Embolization Plugs and Coils Market, United States, Revenue ($m), by Segment, 2015-2025 31
3.1.8 Renal Denervation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 33
3.2 Peripheral Vascular Devices Market, United States, Volume (Units), 2015-2025 35
3.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2015-2025 38
3.2.2 Carotid and Renal Artery Stents Market, United States, Volume (Units), by Segment, 2015-2025 40
3.2.3 Peripheral Embolic Protection Devices Market, United States, Volume (Units), by Segment, 2015-2025 42
3.2.4 Peripheral Guidewires Market, United States, Volume (Units), by Segment, 2015-2025 44
3.2.5 Peripheral Vascular Stents Market, United States, Volume (Units), by Segment, 2015-2025 46
3.2.6 PTA Balloon Catheters Market, United States, Volume (Units), by Segment, 2015-2025 48
3.2.7 PV Embolization Plugs and Coils Market, United States, Volume (Units), by Segment, 2015-2025 50
3.2.8 Renal Denervation Catheters Market, United States, Volume (Units), by Segment, 2015-2025 52
3.3 Peripheral Vascular Devices Market, United States, Average Price ($) , 2015-2025 54
3.4 Peripheral Vascular Devices Market, United States, Distribution Share by Revenue ($m), 2019 58
3.5 Peripheral Vascular Devices Market, United States, Company Share by Revenue ($m), 2019 59
4 Overview of Key Companies in United States, Peripheral Vascular Devices Market 61
4.1 Terumo Medical Corp 61
4.1.1 Company Overview 61
4.2 W. L. Gore & Associates Inc 61
4.2.1 Company Overview 61
4.3 Boston Scientific Corp 61
4.3.1 Company Overview 61
4.4 Medtronic Plc 62
4.4.1 Company Overview 62
4.5 Abbott Laboratories 62
4.5.1 Company Overview 62
4.6 Cook Medical Inc 62
4.6.1 Company Overview 62
4.7 Cordis Corp 63
4.7.1 Company Overview 63
4.8 Penumbra Inc 63
4.8.1 Company Overview 63
4.9 Koninklijke Philips NV 63
4.9.1 Company Overview 63
4.10 CR Bard Inc 63
4.10.1 Company Overview 63
5 Peripheral Vascular Devices Market Pipeline Products 65
6 Financial Deals Landscape 68
6.1 Acquisition 68
6.1.1 Smiths Medical Acquires Access Scientific 68
6.1.2 Terumo to Acquire Aortica 70
6.1.3 Baxter International to Acquire Cheetah Medical from HighCape Capital 71
6.1.4 Siemens Healthineers Acquires Corindus Vascular Robotics 73
6.2 Asset Transactions 75
6.2.1 Vascular Graft Solutions Acquires Intellectual Property from Neograft Technologies 75
6.2.2 Surmodics Acquires Intellectual Property Device Technology 76
6.3 Debt Offerings 77
6.3.1 Stryker Prices Public Offering of
1.15% Notes Due 2025 for USD650 Million 77
6.3.2 Stryker Prices Public Offering of
1.95% Notes Due 2030 for USD1 Billion 79
6.3.3 Stryker Prices Public Offering of
2.9% Notes Due 2050 for USD650 Million 81
6.3.4 Teleflex Prices Private Placement of
4.25% Notes Due 2028 for USD500 Million 83
6.3.5 Boston Scientific Raises USD1.2 Billion in Public Offering of
2.65% Senior Notes due 2030 84
6.3.6 Boston Scientific Raises USD500 Million in Public Offering of
1.9% Senior Notes due 2025 86
6.3.7 Becton Dickinson Raises USD750 Million in Public Offering of
2.823% Notes Due 2030 88
6.3.8 Becton Dickinson Raises USD750 Million in Public Offering of
3.794% Notes Due 2050 90
6.3.9 Intact Vascular Raises USD13.5 Million in Debt Offering 92
6.3.10 Baxter International Raises USD500 Million in Private Placement of
3.95% Senior Notes Due 2030 93
6.3.11 Baxter International Raises USD750 Million in Private Placement of
3.75% Senior Notes Due 2025 94
6.3.12 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 95
6.3.13 Stryker Raises USD881.3 Million in Public Offering of
0.75% Notes Due 2029 97
6.3.14 Stryker Raises USD936.4 Million in Public Offering of
0.25% Notes Due 2024 99
6.3.15 Boston Scientific Raises USD999.2 Million in Public Offering of
0.625% Notes Due 2027 101
6.4 Equity Offerings 103
6.4.1 Aspira Womens Health to Raise USD11 Million in Private Placement of Shares 103
6.4.2 Avinger Raises USD5.4 Million in Public Offering of Shares 104
6.4.3 Cardiovascular Systems Announces Exercise of Over-Allotment Option of Public Offering of Shares for USD143.7 Million 106
6.4.4 Cardiovascular Systems Prices Public Offering of Shares for USD125 Million 108
6.4.5 Hancock Jaffe Lab to Raise USD0.97 Million in Public Offering of Shares 110
6.4.6 Penumbra Prices Public Offering of Shares for USD125 Million 111
6.4.7 Boston Scientific Raises USD1 Billion in Public Offering of Shares 113
6.4.8 Boston Scientific Raises USD1 Billion in Public Offering of
5.5% Mandatory Convertible Preferred Stock 115
6.4.9 Lemaitre Vascular Files Registration Statement for Public Offering of Securities for up to USD200 Million 117
6.4.10 Becton Dickinson Raises USD1.5 Public Offering of Shares 119
6.4.11 Becton Dickinson Raises USD1.5 Billion in Public Offering of Depositary Shares 121
6.4.12 Inari Medical Raises USD179.2 Million in IPO of Shares 124
6.4.13 Silk Road Medical Raises USD305.4 Million in Public Offering of Shares, Including Underwriters’ Exercise of Overallotment Option 126
6.4.14 Hancock Jaffe Laboratories to Raise USD1 Million in Registered Direct Offering 128
6.4.15 Avinger Raises USD3.6 Million in Public Offering of Shares, Including Underwriters Exercise of Over Allotment Option 129
6.4.16 Hancock Jaffe Labs Raises USD0.7 Million in Private Placement of Securities 131
6.4.17 Avinger Raises USD4.5 Million in Public Offering of Shares 132
6.4.18 Avinger Raises USD4.5 Million in Public Offering of Shares 134
6.4.19 Endologix Plans to Raise up to USD75 Million in Public Offering of Shares 136
6.4.20 Silk Road Medical Raises USD190.7 Million in Public Offering of Shares 137
6.4.21 Access Scientific Raises USD20 Million in Private Placement of Shares 139
6.4.22 Nuvectra Plans to Raise up to USD25 Million in Public Offering of Shares 140
6.5 Merger 141
6.5.1 Hancock Jaffe Laboratories Plans to Merge with Catheter Precision 141
6.6 Private Equity 142
6.6.1 Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital 142
7 Recent Developments 143
7.1 Corporate Communications 143
7.1.1 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference 143
7.1.2 Mar 02, 2020: Stryker announces new Investor Relations leader 144
7.1.3 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum 145
7.1.4 Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer 145
7.1.5 Jan 28, 2020: Inari Medical appoints Cynthia Lucchese and Catherine Szyman to the company's Board of Directors 146
7.1.6 Jan 14, 2020: Leading national health plan selects Inovalon’s cloud-based pharmacy platform 146
7.1.7 Jan 10, 2020: Cardiva Medical appoints Jeri Hilleman to the company’s Board of Directors 148
7.1.8 Dec 16, 2019: Avinger appoints Healthcare Veteran Tamara Elias, MD, to board of directors 148
7.1.9 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 149
7.1.10 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 149
7.1.11 Nov 25, 2019: Maggie Yuen appointed Chief Financial Officer of Penumbra 150
7.1.12 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 151
7.1.13 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 151
7.1.14 Oct 28, 2019: ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at AACR-NCI-EORTC Annual Conference 152
7.1.15 Oct 22, 2019: AngioDynamics announces departure of CFO and appointment of interim CFO 153
7.1.16 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 153
7.1.17 Sep 26, 2019: BD announces leadership succession plan 154
7.1.18 Sep 24, 2019: Jaguar Health to host investor call to provide updates regarding development of Mytesi for the potential follow-on indication of cancer therapy-related diarrhea 156
7.1.19 Sep 20, 2019: Nuvectra appoints Jennifer Kosharek as chief financial officer 157
7.1.20 Sep 16, 2019: Hancock Jaffe appoints Global Healthcare Executive Matthew Jenusaitis and Financial and Medical Reimbursement Expert Robert Gray to its board of directors 157
7.1.21 Aug 29, 2019: Sri Kosaraju promoted to President and CFO of Penumbra 158
7.1.22 Aug 28, 2019: Rose Kelly-Falls named global leader of procurement and supply chain for Cook Medical 159
7.1.23 Aug 21, 2019: Rebiotix and Karolinska Institutet expand partnership to shape the future of microbiome research 159
7.1.24 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 160
7.1.25 Aug 12, 2019: Stryker announces commercial structure realignment 160
7.1.26 Aug 05, 2019: REVA receives additional interim funding 160
7.1.27 Jul 31, 2019: AngioDynamics announces appointment of former Johnson & Johnson executive Karen Licitra to its Board of Directors 161
7.1.28 Jul 25, 2019: Cardiovascular Systems announces former U.S. congressman Erik Paulsen joins board of directors 161
7.1.29 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 162
7.2 Financial Announcements 162
7.2.1 Mar 03, 2020: Semler reports record fourth quarter and year end 2019 financial results 162
7.2.2 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 163
7.2.3 Feb 20, 2020: Teleflex reports fourth quarter and full year 2019 results; provides 2020 guidance 164
7.2.4 Feb 20, 2020: Integer Holdings reports results for fourth quarter and full year 2019 166
7.2.5 Feb 19, 2020: Endologix reports fourth quarter and fiscal year 2019 financial results 167
7.2.6 Feb 06, 2020: BD announces results for 2020 first fiscal quarter; lowers fiscal 2020 guidance 169
7.2.7 Feb 06, 2020: LeMaitre Vascular Announces Q4 2019 Financial Results 170
7.2.8 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 171
7.2.9 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance 173
7.2.10 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook 173
7.2.11 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 175
7.2.12 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 176
7.2.13 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance 177
7.2.14 Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results 178
7.2.15 Nov 12, 2019: Vermillion reports third quarter 2019 financial results 179
7.2.16 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 180
7.2.17 Nov 06, 2019: Endologix reports third quarter 2019 financial results 181
7.2.18 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 182
7.2.19 Oct 31, 2019: Teleflex reports third quarter 2019 results 183
7.2.20 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 185
7.2.21 Oct 30, 2019: Semler reports record third quarter and year-to-date 2019 financial results 188
7.2.22 Oct 29, 2019: Stryker reports third quarter 2019 operating results 189
7.2.23 Oct 29, 2019: Cardiovascular Systems reports fiscal 2020 first-quarter financial results 190
7.2.24 Oct 29, 2019: Silk Road Medical reports third quarter 2019 financial results 192
7.2.25 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 192
7.2.26 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 195
7.2.27 Oct 23, 2019: Edwards Lifesciences reports third quarter results 196
7.2.28 Oct 23, 2019: LeMaitre Vascular announces Q3 2019 financial results 199
7.2.29 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 199
7.2.30 Oct 03, 2019: AngioDynamics reports fiscal 2020 first quarter financial results 200
7.2.31 Sep 25, 2019: Katerzia, the first and only amlodipine oral suspension, 1 mg/mL, is now commercially available for pediatric patients 6 years of age and older 201
7.2.32 Sep 02, 2019: Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension 203
7.2.33 Aug 08, 2019: Corindus reports second quarter 2019 results 204
7.2.34 Aug 08, 2019: Endologix reports second quarter 2019 financial results 205
7.2.35 Aug 08, 2019: Vermillion reports second quarter 2019 financial results 205
7.2.36 Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance 207
7.2.37 Aug 06, 2019: Cardiovascular Systems reports fiscal 2019 fourth-quarter financial results 208
7.2.38 Aug 06, 2019: Penumbra reports second quarter 2019 financial results 210
7.2.39 Aug 01, 2019: Teleflex reports second quarter 2019 results 210
7.2.40 Aug 01, 2019: Integer Holdings reports second quarter 2019 results 213
7.2.41 Jul 31, 2019: Nuvectra reports second quarter 2019 financial results 213
7.2.42 Jul 31, 2019: Avinger reports 26% sequential revenue growth in second quarter 2019 214
7.2.43 Jul 29, 2019: Silk Road Medical reports second quarter 2019 financial results and raises 2019 outlook 215
7.2.44 Jul 26, 2019: Semler reports record second quarter and first half 2019 financial results 216
7.2.45 Jul 25, 2019: Baxter reports second-quarter 2019 results 217
7.2.46 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 219
7.2.47 Jul 25, 2019: Stryker reports second quarter 2019 operating results 221
7.2.48 Jul 24, 2019: LeMaitre Vascular announces Q2 2019 financial results 222
7.2.49 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 222
7.2.50 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019 224
7.2.51 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 226
7.2.52 Jul 10, 2019: AngioDynamics reports fiscal 2019 fourth quarter and full-year financial results 227
7.3 Government and Public Interest 228
7.3.1 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 228
7.4 Legal And Regulatory 229
7.4.1 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter 229
7.4.2 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International 229
7.4.3 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 230
7.4.4 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker 231
7.4.5 Jul 25, 2019: BD Statement on Georgia facilities 231
7.5 Other Significant Developments 231
7.5.1 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 231
7.5.2 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol 232
7.5.3 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 234
7.5.4 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 235
7.5.5 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax 235
7.5.6 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 235
7.5.7 Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia 236
7.5.8 Oct 17, 2019: Fujifilm Sonosite Signs agreement with Intelligent Ultrasound Group to develop clinician training 236
7.5.9 Oct 17, 2019: Intelligent Ultrasound Group: Agreement with FUJIFILM SonoSite to develop clinician training 237
7.5.10 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica 238
7.5.11 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 239
7.5.12 Aug 26, 2019: Nuvectra exploring strategic options to enhance shareholder value 240
7.5.13 Aug 01, 2019: Access Scientific unveils partnership with smiths medical to sell access' Powerwand product lines and completion of a $20m capital raise 240
7.5.14 Jul 10, 2019: Medtronic announces the early results of its cash tender offers for up to $5.525 billion of certain outstanding debt securities 241
7.6 Product News 242
7.6.1 Feb 17, 2020: The Latest in Pediatric Heart Disease: Benefits of Skin-to-Skin Care, Nurse-Initiated PIV training and improving cholesterol screening in high-risk patients 242
7.6.2 Oct 14, 2019: Cheetah Medical to present at the CHEST annual meeting 2019 International Conference 245
7.6.3 Jul 23, 2019: ZOLL rebrands Payor Logic Solutions as ZOLL AR Boost 245
7.7 Strategy And Business Planning 246
7.7.1 Jun 25, 2020: Integer Opens New Innovative Ireland Research and Development Facility 246
7.7.2 Feb 20, 2020: Integer acquires Israel-based medical device firm Inomec 246
7.7.3 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 247
7.7.4 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 247
7.7.5 Jul 19, 2019: Midatech announces safety results from first in human study for injectable MidaCore Gold nano particle diabetes vaccine programme – MTX102 248
8 Appendix 250
8.1 Research Methodology 251
8.1.1 Coverage 251
8.1.2 Secondary Research 251
8.1.3 Primary Research 252
8.1.4 Market Modeling and Forecasting 253
8.1.5 Company Share Analysis 255
8.1.6 Distribution Share Analysis 255
8.1.7 Benchmarking 256
8.2 GlobalData Consulting 256
8.3 Contact Us 256
8.4 Disclaimer 257
